Results 201 to 210 of about 251,426 (313)
Electrolyte-Controlled Stripping Behavior of Electroplated Lithium Toward Efficient Lithium Metal Anodes. [PDF]
Hwang J, Kwon H, Kim S, Kim HT.
europepmc +1 more source
CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh +12 more
wiley +1 more source
A Versatile Engineering Platform for the Fabrication of Prosthetic Venous Valves Using Electrospinning. [PDF]
Arcuti D +6 more
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Poly(phosphazene)-Coatings for Stabilizing Silicon Thin-Film Anodes in Lithium-Ion-Batteries. [PDF]
Kneusels NH +7 more
europepmc +1 more source
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
Synergistic Regulation of Nucleation and Interfacial Chemistry for Energy-Dense and Durable Anode-Free Na Batteries. [PDF]
An Y, Pei Z, Yang J, Luan D, Lou XWD.
europepmc +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source

